Schubert Jonckheer & Kolbe LLP advises Verrica Pharmaceuticals Inc. investors that the firm is investigating potential legal claims relating to the company’s unsuccessful efforts in 2021 and 2022 to secure regulatory approval for its drug product VP-102, designed to treat molluscum. Current shareholders are encouraged to contact the firm.
Read MoreNews and Investigations
We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.
We are investigating a data breach impacting the private personal and health information of 468,344 patients and employees of Omni Family Health, a California-based healthcare provider.
Read MoreWe are investigating a data breach impacting the private personal and health information of patients of Boston Children’s Health Physicians, LLP and The Children’s Hospital Corporation d/b/a Boston Children’s Hospital, a network of over 300 pediatric physicians operating in over 60 locations across New York’s Hudson Valley and Connecticut.
Read MoreWe are investigating a data breach impacting the private personal and health information of 108,149 patients of TriCity Healthcare District, the administrator of Tri-City Medical Center, a California-based public hospital.
Read MoreWe are investigating a data breach impacting the private personal and health information of 393,358 medical records held by Gryphon Healthcare, LLC, a Texas-based medical billing provider.
Read MoreWe are investigating a data breach impacting the private personal information of up to 150 million customers of MoneyGram Payment Systems, Inc., a Texas-based peer-to-peer payment and money transfer company.
Read More